A Randomized, Placebo-Controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Multiple Doses of BMS-986165 in Subjects With Active Psoriatic Arthritis (PsA)
ClinicalTrials.gov NCT03881059
Research payments
$695,291
Through program year 2021, $695,291 in research payments was reported against A Randomized, Placebo-Controlled, Double-blind, Multicenter Study to Assess the Efficacy and Safety of Multiple Doses of BMS-986165 in Subjects With Active Psoriatic Arthritis (PsA), across 60 payments, paid by E.R. Squibb & Sons, L.L.C..
- Paid by
- E.R. Squibb & Sons, L.L.C.
- ClinicalTrials.gov
- NCT03881059
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $75,039 | 23 |
| 2020 | Research | $620,252 | 37 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Howard Kenney Spokane, WA Named on 3 payments
- Christopher Ritchlin Rochester, NY Named on 2 payments
- Ramesh Gupta Memphis, TN Named on 2 payments
- Alan Kivitz Duncansville, PA Named on 2 payments
- Shadi Shahouri Wichita, KS Named on 2 payments
- Jacob Aelion Jackson, TN Named on 2 payments
- Jeffrey Neal Lexington, KY Named on 2 payments
- Isam Diab Cleveland, OH Named on 2 payments
- Jennifer Murphy Summerville, SC Named on 2 payments
- Philip Mease Seattle, WA Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.